HCN2 and epilepsy: By describing 21 additional individuals with pathogenic HCN2 variants, we expand the phenotype of HCN2‐related disorders, from mild epilepsies with normal cognition, to phenotypes, including ID with or without epilepsy, individuals with DEE, and movement disorders.